期刊文献+

组织多肽特异性抗原和癌胚抗原在肺癌诊断中价值 被引量:2

The clinical diagnostic value of TPS and CEA in lung cancer
暂未订购
导出
摘要 目的 探讨组织多肽特异性抗原 (TPS)及癌胚抗原 (CEA)对肺癌诊断的临床价值。 方法 用化学免疫荧光法测定38例肺癌及40例良性疾病患者血中TPS水平 ,同时用微粒子酶免分析法测定CEA水平。结果 肺癌组血中TPS、CEA水平均明显高于良性病变组(P<0.01)。TPS的敏感性为81.6 %、特异性为75.0 % ;CEA的敏感性为42.1 %、特异性为92.5 %。两者联合测定敏感性为87.5%、特异性为100%。结论 TPS作为肺癌的标志物敏感性高 ,CEA特异性强。TPS与CEA联合检测对肺癌诊断有很高的特异性 ,对肺癌的诊断有较大的价值。 Objective To explore the clinical diagnostic value of tissue ploypeptide specific antigen(TPS)and carcinoembryonic antigen(CEA)in lung cancer. Methods In20patients with lung cancer and16patients with benign disease,TPS was determined by chemical immunofluorescence and CEA was determined by microaggregate enzyme immunoassay. Results 1.The serum levels of TPS and CEA were significantly higher in the patients with lung cancer than those with benign disease(p<0.01).2.In the diagnosis of lung caner,the sensitivity of TPS and CEA was81.6%,42.1%and the specificity was75.0%,92.5%respectively,moreover,the sensitivity was87.5%and the specificity was100%in combined detection of TPS and CEA. Conclusion The sensitivity of TPS was higher than that of CEA as a marker of lung caner,While the specificity of CEA was much higher than that of TPS.The combined detection of TPS and CEA may improve the sensitivity and specificity in the diagnosis of lung cancer.
出处 《浙江临床医学》 2004年第9期754-755,共2页 Zhejiang Clinical Medical Journal
关键词 组织多肽特异性抗原 癌胚抗原 肺癌 诊断 测定 Lung cancer Diagnosis Tissue ploypeptide specific antigen(TPS)Carcinoembryonic antigen(CEA)
  • 相关文献

参考文献4

  • 1[2]Bjorklund B, Bjorklund V. Antigenicity of poded human Malingnant and Nonnal tissue by cyto - immundogical technique. Presence of an insoluble heatlabile tumor antigen. Int Arch allergy Appl Immunol 1957,10:153 ~160.
  • 2[3]Brechot Jm, cheverel s, Nataf J,et al. Diagnostic and prognostic value of cyfra 21 - 1 compared with other tumor marker in patients with NSCLC,a prospective study of 116 patients. Eur J Cancer, 1997, 33 (3): 385 ~ 393.
  • 3[4]Gold P,Freedman SO.Demonstration of Tumor- Specific Antigens in Human Colonic Carcinomata by Immunological Tolerance and Absorption Techniquce. J Exp Med 1964; 121:439.
  • 4郑航,何本夫,罗荣城.TPS、NSE和CEA联合检测对肺癌的诊断价值[J].第一军医大学学报,2003,23(2):165-166. 被引量:15

二级参考文献2

共引文献14

同被引文献44

  • 1丁湘彧,张宝秋,张洁,王雪玉,尹颜军,荣长利,时广利.肺癌患者血清中肿瘤标志物检测的临床意义[J].中华临床医师杂志(电子版),2011,5(16):4646-4650. 被引量:35
  • 2李海如,郑健,陈亚明,唐桂红,胥亚兰.口腔鳞癌患者血清催乳素的变化对预后的影响[J].口腔医学,2004,24(5):272-273. 被引量:3
  • 3吕志强,李海刚,谢德荣,张惠忠,沈溪明,曾韵洁,曾弘.非小细胞肺癌组织中VEGF-C和VEGFR-3的表达及其临床意义[J].癌症,2005,24(9):1132-1135. 被引量:22
  • 4Stieber P,Dinemann H,Schalhorn A,et al.Pro-gastrin-releasing Peptide (ProGRP),A useful marker in small cell lung carcinomas[J].Anticancer Res,1999,19:2673–2678.
  • 5Molina R,Filella X,Auge J M.ProGRP:a new biomarker for small cell lung cancer[J].Clin Biochem,2004,37:505–511.
  • 6Takada M,Kusunoki Y,Masuda N,et al.Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer:comparative evaluation with neuron-specific enolase[J].Br J Cancer,1996,73(10):1227-1232.
  • 7Schneider J,Philipp M,Salewski L,et al.Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer[J].Clin Lab,2003,49:35–42.
  • 8Molina R,Filella X,Augé J M,et al.Tumor markers (CEA,CA 125,CYFRA 21-1,SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis.Comparison with the main clinical and pathological prognostic factors[J].Tumour Biol,2003,24(4):209-218.
  • 9Matsuoka K,Sumitomo S,Nakashima N,et al.Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer[J].Eur J Cardiothorac Surg,2007,32(3):435-439.
  • 10Buccheri G and Ferrigno D.Identifying patients at risk of early postoperative recurrence of lung cancer:a new use of the old CEA test[J].Ann Thorac surg,2003,75(3):973-980.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部